• 1
    Cohen ML, Tauxe RV. Drug-resistant Salmonella in the United States: an epidemiology perspective. Science 1986; 234: 964969.
  • 2
    Mead PS, Slutsker L, Dietz V et al. Food-related illness and death in the United States. Emerg Infect Dis 1999; 5: 607625.
  • 3
    Tauxe RV. Emerging foodborne disease: an evolving public health challenge. Emerg Infect Dis 1997; 3: 425434.
  • 4
    Chiu CH, Lin TY, Ou JT. Predictors for extraintestinal infection of non-typhoid Salmonella in patients without AIDS. Int J Clin Pract 1999; 53: 161164.
  • 5
    Torrey S, Fleisher G, Jaffe D. Incidence of Salmonella bacteremia in infants with Salmonella gastroenteritis. J Pediatr 1986; 108: 718721.
  • 6
    Sirinavin S, Jayanetra P, Thakkistian A. Clinical and prognostic categorization of extraintestinal nontyphoidal Salmonella infections in infants and children. Clin Infect Dis 1999; 29: 11511156.
  • 7
    Aserkoff B, Bennett JV. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N Engl J Med 1969; 281: 636640.
  • 8
    Chiu CH, Lin TY, Ou JT. A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enterocolitis in children. J Paediatr Child Health 1999; 35: 372374.
  • 9
    American Academy of Pediatrics. Salmonella infections. In: PickeringLK, ed. 2009 Red book: report of the committee on infectious diseases, 28th edn. Elk Grove Village, IL: American Academy of Pediatrics, 2009; 584589.
  • 10
    Wistrom J, Jertborn M, Ekwall E et al. Empiric treatment of acute diarrheal disease with norfloxacin: a randomized placebo controlled study. Swedish Study Group. Ann Intern Med 1992; 117: 202208.
  • 11
    Su LH, Chiu CH. Salmonella: clinical importance and evolution of nomenclature. Chang Gung Med J 2007; 30: 210218.
  • 12
    Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoidal Salmonella serotypes: a global challenge. Clin Infect Dis 2004; 39: 546551.
  • 13
    Su LH, Wu TL, Chia JH, Chu C, Kuo AJ, Chiu CH. Increased ceftriaxone resistance in Salmonella isolates: from a university hospital in Taiwan. J Antimicrob Chemother 2005; 55: 846852.
  • 14
    Cherubin CE, Eng RH, Smith SM, Goldstein EJ. Cephalosporin therapy for salmonellosis. Arch Intern Med 1986; 146: 21492152.
  • 15
    Bryan JP, Scheld WM. Therapy of experimental meningitis due to Salmonella enteritidis. Antimicrob Agents Chemother 1992; 36: 949954.
  • 16
    Ti T, Monteiro EH, Lam S, Lee H. Ceftriaxone therapy in bacteremic typhoid fever. Antimicrob Agents Chemother 1985; 28: 540543.
  • 17
    Chiu CH, Wu TL, Su LH et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 2002; 346: 413419.
  • 18
    Farmer JJ. Enterobacteriaceae: introduction and identification. In: MurrayPR, BaronEJ, PfallerMA, eds, Manual of clinical microbiology, 6th edn. Washington, DC: American Society of Microbiology, 1995; 438449.
  • 19
    Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing. Document M100-S17. Wayne, PA: CLSI, 2007.
  • 20
    Huang IF, Wagener MM, Hsieh KS et al. Nontyphoid salmonellosis in Taiwan children: clinical manifestations, outcomes and antibiotic resistance. J Pediatr Gastroenterol Nutr 2004; 38: 518523.
  • 21
    Helms M, Vastrup P, Gerner-Smidt P, Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis 2002; 8: 490495.
  • 22
    Sirinavin S, Garner P. Antibiotics for treating salmonella gut infections. Cochrane Database Syst Rev 2000; 2: CD001167.
  • 23
    Su LH, Chiu CH, Kuo AJ et al. Secular trends in incidence and antimicrobial resistance among clinical isolates of Salmonella at a university hospital in Taiwan, 1983–1999. Epidemiol Infect 2001; 127: 207213.
  • 24
    Nelson JD, Kusmiesz H, Jackson LH, Woodman E. Treatment of Salmonella gastroenterocolitis with ampicillin, amoxicillin, or placebo. Pediatrics 1980; 65: 11251130.
  • 25
    Garcia-del Portillo F. Salmonella intracellular proliferation: where, when and how? Microbes Infect 2001; 3: 13051311.
  • 26
    Lin TY, Chiu CH, Lin PY, Wang MH, Su LH, Lin TY. Short-term ceftriaxone therapy for treatment of severe non-typhoidal Salmonella enterocolitis. Acta Paediatr 2003; 92: 537540.
  • 27
    Anton PA, Kemp JA, Butler T, Jacobs MR. Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection. Antimicrob Agents Chemother 1982; 22: 312315.
  • 28
    Chiu CH, Lin TY, Ou JT. In vitro evaluation of intracellular activity of antibiotics against nontyphoid Salmonella. Int J Antimicrob Agents 1999; 11: 4752.